Janney Capital Management Llc decreased its stake in Sap Se Spons Adr (SAP) by 1.89% based on its latest 2018Q1 regulatory filing with the SEC. Janney Capital Management Llc sold 3,200 shares as the company’s stock rose 8.28% while stock markets declined. The institutional investor held 165,786 shares of the prepackaged software company at the end of 2018Q1, valued at $17.43M, down from 168,986 at the end of the previous reported quarter. Janney Capital Management Llc who had been investing in Sap Se Spons Adr for a number of months, seems to be less bullish one the $144.74B market cap company. The stock decreased 0.16% or $0.2 during the last trading session, reaching $121.18. About 544,123 shares traded. SAP SE (NYSE:SAP) has risen 6.76% since June 16, 2017 and is uptrending. It has underperformed by 5.81% the S&P500. Some Historical SAP News: 18/04/2018 – Accenture to Help Orkla Drive Digital Services and Growth Through SAP S/4HANA®; 05/04/2018 – SAP: Strategic Move Will Strengthen Intelligent Customer Experience Suite of Solutions; 26/04/2018 – Onapsis Helps SAP Customers Identify and Fix Widespread Critical Security Configuration Risk; 08/05/2018 – Onapsis Launches New Functionality to Lock Down SAP Systems; 07/05/2018 – Former SAP Media Executive Appointed Co-Founder by Ad-tech Start-Up, Adzymic, Focusing on Dynamic Creative Management Solution; 08/03/2018 – Ameri100 Leverages Client Base for First SAP Cloud Platform Award; 16/04/2018 – There is a big push toward cloud computing in Saudi Arabia, according to Luka Mucic, chief financial officer at SAP; 03/05/2018 – Accenture to Co-Develop Digital Defense and Security Solution with SAP, Helping Defense Agencies Accelerate Digital; 07/03/2018 – Moody’s Assigns A2 Rating To Sap’s New Notes; Outlook Stable; 08/03/2018 – SAP: Probe Found ‘Indications of Misconduct’ in Payments to Gupta-Related Companies
Hendley & Co Inc increased its stake in Johnson & Johnson (JNJ) by 5.46% based on its latest 2018Q1 regulatory filing with the SEC. Hendley & Co Inc bought 3,270 shares as the company’s stock declined 8.03% with the market. The institutional investor held 63,209 shares of the major pharmaceuticals company at the end of 2018Q1, valued at $8.10 million, up from 59,939 at the end of the previous reported quarter. Hendley & Co Inc who had been investing in Johnson & Johnson for a number of months, seems to be bullish on the $328.86B market cap company. The stock increased 0.16% or $0.2 during the last trading session, reaching $122.61. About 13.17M shares traded or 95.52% up from the average. Johnson & Johnson (NYSE:JNJ) has declined 4.75% since June 16, 2017 and is downtrending. It has underperformed by 17.32% the S&P500. Some Historical JNJ News: 16/03/2018 – J&J – DEAL FOR APPROXIMATELY $2.1 BLN,; 16/03/2018 – Johnson & Johnson Sees Deal Closing by End of 2018 If Offer Accepted; 24/04/2018 – J&J Bond Trading 2x Average; Clients Net Buyers; 21/03/2018 – Bloomberg Big Decisions: Johnson & Johnson CEO Alex Gorsky (Video); 15/05/2018 – Wolverine Adds J&J, Exits Aflac, Cuts Exxon: 13F; 10/04/2018 – J&J Presenting at Deutsche Bank Health Care Conference May 9; 16/03/2018 – Johnson & Johnson Gets $2.1 Billion Offer for Blood Glucose Monitoring Business; 15/05/2018 – STAT Plus: Pharmalittle: J&J and AbbVie roll back price hike after criticism; FDA to call out companies that thwart generics; 05/04/2018 – J&J, lmerys must pay $37 mln in case over talc cancer risks -jury; 02/05/2018 – $JNJ acquires BeneVir for $140M upfront + $900M milestone $MRK acquires Viralytics for $394M Oncolytic virus back to be the hot thing in I/O again? More $AMGN T-Vec + PD1 combo data to come at #ASCO18
More notable recent SAP SE (NYSE:SAP) news were published by: Prnewswire.com which released: “Cintas Unifies Employee Experience with SAP® SuccessFactors® Solutions” on June 12, 2018, also Seekingalpha.com with their article: “The Business Of Business Software” published on June 14, 2018, Prnewswire.com published: “SAP Debuts Technology Innovations to Optimize Performance for the German Football Association (DFB) at the World …” on June 15, 2018. More interesting news about SAP SE (NYSE:SAP) were released by: Prnewswire.com and their article: “SAPPHIRE NOW 2018 Financial Analyst Conference” published on June 06, 2018 as well as Prnewswire.com‘s news article titled: “SAP to Team with Accenture, Capgemini and Deloitte to Accelerate Customer Adoption of SAP S/4HANA® Cloud in …” with publication date: June 04, 2018.
Janney Capital Management Llc, which manages about $3.30B and $2.30B US Long portfolio, upped its stake in Zimmer Biomet Hldgs Inc (ZMH) by 3,631 shares to 144,841 shares, valued at $15.79M in 2018Q1, according to the filing. It also increased its holding in Ft Iv Tacticl Hi Yld Etf (HYLS) by 97,387 shares in the quarter, for a total of 776,373 shares, and has risen its stake in Ishs 13Y Cr Bd Etf (CSJ).
Among 21 analysts covering Sap Ag (NYSE:SAP), 13 have Buy rating, 1 Sell and 7 Hold. Therefore 62% are positive. Sap Ag had 62 analyst reports since July 23, 2015 according to SRatingsIntel. The company was maintained on Tuesday, October 10 by Stifel Nicolaus. The firm has “Hold” rating given on Friday, April 20 by RBC Capital Markets. The company was maintained on Wednesday, January 11 by JMP Securities. The rating was maintained by Stifel Nicolaus with “Sell” on Thursday, March 1. The firm has “Hold” rating given on Monday, August 28 by Jefferies. On Tuesday, January 30 the stock rating was maintained by BMO Capital Markets with “Hold”. Cowen & Co maintained it with “Buy” rating and $113.0 target in Friday, October 13 report. JP Morgan upgraded SAP SE (NYSE:SAP) on Tuesday, September 15 to “Overweight” rating. Berenberg upgraded SAP SE (NYSE:SAP) on Tuesday, April 12 to “Buy” rating. The rating was maintained by RBC Capital Markets on Wednesday, January 24 with “Hold”.
Analysts await SAP SE (NYSE:SAP) to report earnings on July, 19. They expect $0.98 earnings per share, up 28.95% or $0.22 from last year’s $0.76 per share. SAP’s profit will be $1.17 billion for 30.91 P/E if the $0.98 EPS becomes a reality. After $0.82 actual earnings per share reported by SAP SE for the previous quarter, Wall Street now forecasts 19.51% EPS growth.
Investors sentiment increased to 0.93 in Q1 2018. Its up 0.06, from 0.87 in 2017Q4. It improved, as 63 investors sold JNJ shares while 831 reduced holdings. 111 funds opened positions while 720 raised stakes. 1.71 billion shares or 0.80% less from 1.72 billion shares in 2017Q4 were reported. Retirement Of Alabama reported 1.91 million shares. Moreover, Saturna has 2.52% invested in Johnson & Johnson (NYSE:JNJ). Boyd Watterson Asset Ltd Liability Company Oh has invested 1.09% in Johnson & Johnson (NYSE:JNJ). The Japan-based Hikari Power Ltd has invested 2.96% in Johnson & Johnson (NYSE:JNJ). Sadoff Inv Mgmt invested 0.1% in Johnson & Johnson (NYSE:JNJ). Schmidt P J Management Incorporated holds 2.22% in Johnson & Johnson (NYSE:JNJ) or 59,181 shares. Washington Trust holds 0.86% of its portfolio in Johnson & Johnson (NYSE:JNJ) for 113,976 shares. First Commonwealth Fincl Pa has invested 1.57% of its portfolio in Johnson & Johnson (NYSE:JNJ). Burt Wealth Advsr invested in 0.85% or 13,098 shares. Moreover, Ativo Capital Mngmt Limited Liability Corporation has 0.65% invested in Johnson & Johnson (NYSE:JNJ) for 17,787 shares. Kentucky Retirement has invested 1.53% of its portfolio in Johnson & Johnson (NYSE:JNJ). Flossbach Von Storch Ag, a Germany-based fund reported 2.32 million shares. Clifford Swan Inv Counsel Limited Company invested 2.2% in Johnson & Johnson (NYSE:JNJ). Kopp Advsr Limited Liability Company reported 6,072 shares. Moreover, Cambiar Ltd Liability Corp has 0.75% invested in Johnson & Johnson (NYSE:JNJ) for 367,943 shares.
Since February 15, 2018, it had 0 insider purchases, and 1 insider sale for $20.17 million activity.
Among 23 analysts covering Johnson & Johnson (NYSE:JNJ), 11 have Buy rating, 5 Sell and 7 Hold. Therefore 48% are positive. Johnson & Johnson had 102 analyst reports since August 7, 2015 according to SRatingsIntel. On Wednesday, July 20 the stock rating was upgraded by Argus Research to “Buy”. The rating was maintained by Jefferies with “Hold” on Tuesday, March 15. The rating was maintained by Wells Fargo on Wednesday, October 18 with “Buy”. Credit Suisse maintained the stock with “Outperform” rating in Friday, April 20 report. On Wednesday, October 18 the stock rating was maintained by Stifel Nicolaus with “Hold”. The company was downgraded on Tuesday, November 29 by Barclays Capital. The stock of Johnson & Johnson (NYSE:JNJ) earned “Buy” rating by Leerink Swann on Wednesday, October 18. The company was maintained on Wednesday, October 18 by Morgan Stanley. The stock of Johnson & Johnson (NYSE:JNJ) earned “Buy” rating by RBC Capital Markets on Sunday, August 27. The rating was initiated by Standpoint Research on Friday, May 20 with “Sell”.
More notable recent Johnson & Johnson (NYSE:JNJ) news were published by: Seekingalpha.com which released: “How Do You Feel About Johnson & Johnson?: Part IV – Today’s Editors’ Picks” on June 01, 2018, also Seekingalpha.com with their article: “Avoiding The ‘Black Hole’ Of Disease Development” published on June 15, 2018, Seekingalpha.com published: “Recent Purchase: Johnson & Johnson” on June 14, 2018. More interesting news about Johnson & Johnson (NYSE:JNJ) were released by: Seekingalpha.com and their article: “Johnson & Johnson (JNJ) Presents at Goldman Sachs 39th Annual Global Healthcare Conference Call (Transcript)” published on June 12, 2018 as well as Fool.com‘s news article titled: “Better Buy: Verizon Communications Inc. vs. Johnson & Johnson” with publication date: June 11, 2018.